Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
4.810
-0.140 (-2.83%)
At close: Aug 1, 2025, 4:00 PM
4.790
-0.020 (-0.42%)
After-hours: Aug 1, 2025, 4:10 PM EDT

Monte Rosa Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
Net Income
6.15-72.7-135.35-108.5-73.96-35.88
Upgrade
Depreciation & Amortization
10.1710.228.323.752.130.54
Upgrade
Loss (Gain) From Sale of Assets
-0.06--0.02-0.110.02-
Upgrade
Loss (Gain) From Sale of Investments
-3.91-2.95-3.78-1.95--
Upgrade
Stock-Based Compensation
18.5518.1316.6711.665.20.35
Upgrade
Other Operating Activities
-1.9-2.1-2.14.810.967.68
Upgrade
Change in Accounts Receivable
-0.890.331.9-0.19--
Upgrade
Change in Accounts Payable
0.456.255.76-0.74-0.713.44
Upgrade
Change in Unearned Revenue
0.583.3850---
Upgrade
Change in Other Net Operating Assets
5.61.4414.81-1.26.990.82
Upgrade
Operating Cash Flow
34.6742-43.8-92.47-59.36-23.05
Upgrade
Capital Expenditures
-4.19-3.99-19.04-12.91-9.73-3.39
Upgrade
Sale of Property, Plant & Equipment
--0.060.110.08-
Upgrade
Investment in Securities
-150.34-40.46107.78-206.42--
Upgrade
Investing Cash Flow
-154.53-44.4588.8-219.22-9.65-3.39
Upgrade
Issuance of Common Stock
52.352.532.6121.45255.79-
Upgrade
Other Financing Activities
46.3646.3624.88-0.98-21.23-0.44
Upgrade
Financing Cash Flow
98.6698.8927.4920.47377.5660.06
Upgrade
Net Cash Flow
-21.2196.4472.49-291.22308.5533.62
Upgrade
Free Cash Flow
30.4838.01-62.84-105.38-69.1-26.44
Upgrade
Free Cash Flow Margin
19.11%50.26%----
Upgrade
Free Cash Flow Per Share
0.380.51-1.22-2.23-2.76-17.43
Upgrade
Levered Free Cash Flow
40.5481.97-53.37-72.4-61.297.6
Upgrade
Unlevered Free Cash Flow
40.5481.97-53.37-72.4-61.297.6
Upgrade
Change in Net Working Capital
-17.34-108.31-30.254.6613.34-27.61
Upgrade
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q